Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/1320 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
2024/05/1320 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNCXQuince Therapeutics Inc
2024/05/1320 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITRMIterum Therapeutics PLC
2024/05/1320 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
2024/05/1320 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
2024/05/1320 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBRXMoleculin Biotech Inc
2024/05/1320 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:LACLithium Americas Corp NEW
2024/05/1320 : 30Business WireRedwire Announces Development of New European-Built Very Low Earth Orbit (VLEO) Spacecraft Platform called PhantomNYSE:RDWRedwire Corporation
2024/05/1320 : 30GlobeNewswire Inc.Auction result of Treasury Bills - RIKV 24 0717 - RIKV 24 1120
2024/05/1320 : 30Business WireAPi Group Announces Successful Completion of Debt Refinancing and Provides Update on Upcoming Investor ConferenceNYSE:APGAPi Group Corporation
2024/05/1320 : 30Business WireReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
2024/05/1320 : 30Business WireCorporate Update: Sensible Meats' Cash Position and Future Plans for Change of Business
2024/05/1320 : 30Business WireVecima to Deploy Game-Changing MediaScale Open CDN™ Solution with Youcast in BrazilTSX:VCMVecima Networks Inc
2024/05/1320 : 30GlobeNewswire Inc.Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024NASDAQ:PSTVPlus Therapeutics Inc
2024/05/1320 : 30Business WireNET Power Reports First Quarter 2024 Results and Provides Business UpdateNYSE:NPWRNET Power Inc
2024/05/1320 : 30GlobeNewswire Inc.CLM Announces Management and Board ChangesZ36
2024/05/1320 : 30Business WireToronto accueillera la prestigieuse Coupe internationale des chefs d’Aramark 2024NYSE:ARMKAramark
2024/05/1320 : 30Business WireBowman Adds Vijay Agrawal as Executive Vice President, National Ports & Harbors PracticeNASDAQ:BWMNBowman Consulting Group Ltd
2024/05/1320 : 30GlobeNewswire Inc.Spectral Medical Announces First Quarter Results and Provides Corporate UpdateTSX:EDTSpectral Medical Inc
2024/05/1320 : 30GlobeNewswire Inc.DeFi Technologies Subsidiary Valour Inc. Launches Internet Computer (ICP) and Toncoin (TON) ETPs, Landmark Offerings in the Nordics Alongside Chainlink (LINK) ETPTG:R9BDeFi Technologies Inc
2024/05/1320 : 30GlobeNewswire Inc.CLM Announces Management and Board ChangesTSXV:CLMConsolidated Lithium Metals Inc
2024/05/1320 : 30GlobeNewswire Inc.Avalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
2024/05/1320 : 30GlobeNewswire Inc.Titan Medical Reports Financial Results for the First Quarter 2024TSX:TMDTitan Medical Inc
2024/05/1320 : 30GlobeNewswire Inc.Aqua-Tots Swim School Gets Ready to Jump into Lakeside Community in Forsyth County, Georgia
2024/05/1320 : 30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferencesNASDAQ:MGNXMacroGenics Inc
2024/05/1320 : 30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
2024/05/1320 : 30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” All of Crown Castle’s Director NomineesNYSE:CCICrown Castle Inc
2024/05/1320 : 30GlobeNewswire Inc.Alaska Energy Metals Advances Core Asset Focus With Sale of Mexico Subsidiary and ShareholdingTSXV:AEMCAlaska Energy Metals Corporation
2024/05/1320 : 30GlobeNewswire Inc.Enovix Begins Customer Sampling of EX-1M BatteriesNASDAQ:ENVXEnovix Corporation
2024/05/1320 : 30GlobeNewswire Inc.BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantly Reduced All-Cause Mortality in a Pre-specified SensitiNASDAQ:BBIOBridgeBio Pharma Inc

最近閲覧した銘柄

Delayed Upgrade Clock